Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Journal of Visualized Experiments - United States
doi 10.3791/60130
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MyJove Corporation

Related search

Maximizing Mutagenesis With Solubilized CRISPR-Cas9 Ribonucleoprotein Complexes

Development (Cambridge)
Developmental BiologyMolecular Biology
2016English

Paradoxical Enhancement of Leukemogenesis in Acute Myeloid Leukemia With Moderately Attenuated RUNX1 Expressions

Blood advances
Hematology
2017English

Rapid Generation of Endogenously Driven Transcriptional Reporters in Cells Through CRISPR/Cas9

Scientific Reports
Multidisciplinary
2015English

Efficient Generation of Isogenic Primary Human Myeloid Cells Using CRISPR-Cas9 Ribonucleoproteins

2020English

Generation of Endogenous BMP Transcriptional Reporter Cells Through CRISPR/Cas9 Genome Editing

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

High Expression of RUNX1 Is Associated With Poorer Outcomes in Cytogenetically Normal Acute Myeloid Leukemia

Oncotarget
Oncology
2016English

Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Mediation Analysis Reveals Common Mechanisms of RUNX1 Point Mutations and RUNX1/RUNX1T1 Fusions Influencing Survival of Patients With Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2018English

The Role of TP53 in Acute Myeloid Leukemia: Challenges and Opportunities

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy